A Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
To determine if RTB101 as compared to placebo decreases the percentage of subjects with clinically symptomatic respiratory illness (with or without an associated laboratory-confirmed pathogen) through Week 16.
Epistemonikos ID: 2ba690f2ab9cddba20aba5e5642c9915279766e3
First added on: May 08, 2024